{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:09:47Z","timestamp":1774577387485,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006564","name":"Bozok \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.msard.2019.101524","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T03:28:50Z","timestamp":1573702130000},"page":"101524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: A preliminary project"],"prefix":"10.1016","volume":"38","author":[{"given":"Hikmet","family":"Sa\u00e7mac\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seda","family":"Sabah \u00d6zcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2019.101524_bib0001","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/bmc-2016-0026","article-title":"Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis","volume":"8","author":"Alsahebfosoul","year":"2017","journal-title":"Biomol. Concepts"},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni.2812","article-title":"New nomenclature for atypical chemokine receptors","volume":"15","author":"Bachelerie","year":"2014","journal-title":"Nat. Immunol."},{"issue":"16","key":"10.1016\/j.msard.2019.101524_bib0003","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/bph.13182","article-title":"An atypical addition to the chemokine receptor nomenclature: Iuphar review 15","volume":"172","author":"Bachelerie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.msard.2019.101524_bib0004","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fimmu.2016.00691","article-title":"ACKR2: an atypical chemokine receptor regulating lymphatic biology","volume":"7","author":"Bonavita","year":"2017","journal-title":"Front. Immunol"},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2007-08-108316","article-title":"Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation","volume":"112","author":"Bonecchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.msard.2019.101524_bib0006","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fimmu.2016.00224","article-title":"Atypical chemokine receptors and their roles in the resolution of the inflammatory response","volume":"7","author":"Bonecchi","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2019.101524_bib0007","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fimmu.2016.00224","article-title":"Atypical chemokine receptors and their roles in the resolution of the inflammatory response","volume":"7","author":"Bonecchi","year":"2016","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.msard.2019.101524_bib0008","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.4049\/jimmunol.172.8.4972","article-title":"Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine\/CC chemokine ligand 22) by the D6 decoy receptor","volume":"172","author":"Bonecchi","year":"2004","journal-title":"J. Immunol."},{"issue":"273","key":"10.1016\/j.msard.2019.101524_bib0009","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1126\/scisignal.2003627","article-title":"beta-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6","volume":"6","author":"Borroni","year":"2013","journal-title":"Sci. Signal"},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.wco.0000169736.60922.20","article-title":"The spectrum of multiple sclerosis: new lessons from pathology","volume":"18","author":"Bruck","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.wco.0000169736.60922.20","article-title":"The spectrum of multiple sclerosis: new lessons from pathology","volume":"18","author":"Br\u00fcck","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2019.101524_bib0037","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/icb.2014.15","article-title":"Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis","volume":"92","author":"Chuluundorj","year":"2014","journal-title":"Immunology and cell biology"},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0012","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2011.11.007","article-title":"Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients","volume":"142","author":"Christophi","year":"2012","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2019.101524_bib0013","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.4049\/jimmunol.0803067","article-title":"IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex","volume":"183","author":"Espinassous","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2019.101524_bib0014","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.1303236","article-title":"Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes","volume":"193","author":"Ford","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2019.101524_bib0034","series-title":"Brain and behavior","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","author":"Garg","year":"2015"},{"issue":"Pt 8","key":"10.1016\/j.msard.2019.101524_bib0015","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2019.101524_bib0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/path.4123","article-title":"Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6","volume":"229","author":"Graham","year":"2013","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.msard.2019.101524_bib0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/icb.2014.90","article-title":"The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens","volume":"93","author":"Hansell","year":"2015","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.msard.2019.101524_bib0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/icb.2014.90","article-title":"The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens","volume":"93","author":"Hansell","year":"2015","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.msard.2019.101524_bib0019","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s12035-016-9846-x","article-title":"Cytokine profile in patients with progressive multiple sclerosis and its association with disease progression and disability","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11481-013-9439-7","article-title":"Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases","volume":"8","author":"Kempuraj","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"11","key":"10.1016\/j.msard.2019.101524_bib0021","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101524_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/615130","article-title":"Pathophysiological roles of cytokine-chemokine immune network","author":"Kwak","year":"2014","journal-title":"Journal of immunology research"},{"issue":"2","key":"10.1016\/j.msard.2019.101524_bib0022","first-page":"352","article-title":"Multiple sclerosis: new aspects of immunopathogenesis","volume":"57","author":"Lazibat","year":"2018","journal-title":"Acta Clin. Croat."},{"issue":"1","key":"10.1016\/j.msard.2019.101524_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.177.1.17","article-title":"Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis","volume":"177","author":"Liu","year":"2006","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.msard.2019.101524_bib0024","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nri1964","article-title":"Tuning inflammation and immunity by chemokine sequestration: decoys and more","volume":"6","author":"Mantovani","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2019.101524_bib0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1189\/jlb.3MA0915-444RR","article-title":"CCRL2 regulates M1\/M2 polarization during EAE recovery phase","volume":"99","author":"Mazzon","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"18","key":"10.1016\/j.msard.2019.101524_bib0026","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2012-04-425314","article-title":"An analysis of the function and expression of D6 on lymphatic endothelial cells","volume":"121","author":"McKimmie","year":"2013","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.msard.2019.101524_bib0027","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2012-04-425314","article-title":"An analysis of the function and expression of D6 on lymphatic endothelial cells","volume":"121","author":"McKimmie","year":"2013","journal-title":"Blood"},{"issue":"5025","key":"10.1016\/j.msard.2019.101524_bib0028","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1126\/science.1891716","article-title":"Cloning of complementary DNA encoding a functional human interleukin-8 receptor","volume":"253","author":"Murphy","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.msard.2019.101524_bib0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view","volume":"5","author":"Ortega\u2010G\u00f3mez","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.msard.2019.101524_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.12174","article-title":"Emerging role of interleukin\u201033 in autoimmune diseases","volume":"141","author":"Pei","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.msard.2019.101524_bib0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnagi.2017.00148","article-title":"Role of atypical chemokine receptors in microglial activation and polarization","volume":"9","author":"Salvi","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"1-2","key":"10.1016\/j.msard.2019.101524_bib0038","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(97)00136-7","article-title":"Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis","volume":"80","author":"Sarchielli","year":"1997","journal-title":"Journal of neuroimmunology"},{"issue":"5","key":"10.1016\/j.msard.2019.101524_bib0031","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nri2972","article-title":"Overcoming hurdles in developing successful drugs targeting chemokine receptors","volume":"11","author":"Schall","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2019.101524_bib0032","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/cvr\/cvv150","article-title":"Chemokines as effector and target molecules in vascular biology","volume":"107","author":"Sozzani","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.msard.2019.101524_bib0033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2011.02.045","article-title":"Production and functions of IL-33 in the central nervous system","volume":"1385","author":"Yasuoka","year":"2011","journal-title":"Brain Res."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819308454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819308454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:27Z","timestamp":1761900567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819308454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S2211034819308454"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.101524","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: A preliminary project","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.101524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101524"}}